Frederick BA - Search Results

1

The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomas.

Anderson RT, Keysar SB, Bowles DW, Glogowska MJ, Astling DP, Morton JJ, Le P, Umpierrez A, Eagles-Soukup J, Gan GN, Vogler BW, Sehrt D, Takimoto SM, Aisner DL, Wilhelm F, Frederick BA, Varella-Garcia M, Tan AC, Jimeno A. Anderson RT, et al. Among authors: frederick ba. Mol Cancer Ther. 2013 Oct;12(10):1994-2005. doi: 10.1158/1535-7163.MCT-13-0206. Epub 2013 Jul 19. Mol Cancer Ther. 2013. PMID: 23873848 Free PMC article.

2

Hedgehog signaling drives radioresistance and stroma-driven tumor repopulation in head and neck squamous cancers.

Gan GN, Eagles J, Keysar SB, Wang G, Glogowska MJ, Altunbas C, Anderson RT, Le PN, Morton JJ, Frederick B, Raben D, Wang XJ, Jimeno A. Gan GN, et al. Cancer Res. 2014 Dec 1;74(23):7024-36. doi: 10.1158/0008-5472.CAN-14-1346. Epub 2014 Oct 8. Cancer Res. 2014. PMID: 25297633 Free PMC article.

3

Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous Carcinoma.

Keysar SB, Gomes N, Miller B, Jackson BC, Le PN, Morton JJ, Reisinger J, Chimed TS, Gomez KE, Nieto C, Frederick B, Pronk GJ, Somerset HL, Tan AC, Wang XJ, Raben D, Su TT, Jimeno A. Keysar SB, et al. Cancer Res. 2020 Mar 1;80(5):1183-1198. doi: 10.1158/0008-5472.CAN-19-3232. Epub 2020 Jan 7. Cancer Res. 2020. PMID: 31911553 Free PMC article.

4

Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.

Rothschild BL, Shim AH, Ammer AG, Kelley LC, Irby KB, Head JA, Chen L, Varella-Garcia M, Sacks PG, Frederick B, Raben D, Weed SA. Rothschild BL, et al. Cancer Res. 2006 Aug 15;66(16):8017-25. doi: 10.1158/0008-5472.CAN-05-4490. Cancer Res. 2006. PMID: 16912177

5

Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma.

Frederick BA, Helfrich BA, Coldren CD, Zheng D, Chan D, Bunn PA Jr, Raben D. Frederick BA, et al. Mol Cancer Ther. 2007 Jun;6(6):1683-91. doi: 10.1158/1535-7163.MCT-07-0138. Epub 2007 May 31. Mol Cancer Ther. 2007. PMID: 17541031

6

Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenografts.

Gustafson DL, Frederick B, Merz AL, Raben D. Gustafson DL, et al. Cancer Chemother Pharmacol. 2008 Feb;61(2):179-88. doi: 10.1007/s00280-007-0460-5. Epub 2007 Mar 29. Cancer Chemother Pharmacol. 2008. PMID: 17393165

7

Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma.

Tyagi A, Gu M, Takahata T, Frederick B, Agarwal C, Siriwardana S, Agarwal R, Sclafani RA. Tyagi A, et al. Clin Cancer Res. 2011 Aug 15;17(16):5402-11. doi: 10.1158/1078-0432.CCR-11-1072. Epub 2011 Jun 24. Clin Cancer Res. 2011. PMID: 21705453 Free PMC article.

8

PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models.

Hernandez AL, Young CD, Bian L, Weigel K, Nolan K, Frederick B, Han G, He G, Devon Trahan G, Rudolph MC, Jones KL, Oweida AJ, Karam SD, Raben D, Wang XJ. Hernandez AL, et al. Clin Cancer Res. 2020 Jun 15;26(12):3058-3070. doi: 10.1158/1078-0432.CCR-19-0514. Epub 2020 Mar 5. Clin Cancer Res. 2020. PMID: 32139402 Free PMC article.

9

Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells.

Marshall ME, Hinz TK, Kono SA, Singleton KR, Bichon B, Ware KE, Marek L, Frederick BA, Raben D, Heasley LE. Marshall ME, et al. Among authors: frederick ba. Clin Cancer Res. 2011 Aug 1;17(15):5016-25. doi: 10.1158/1078-0432.CCR-11-0050. Epub 2011 Jun 14. Clin Cancer Res. 2011. PMID: 21673064 Free PMC article.

10

Noninvasive imaging and quantification of epidermal growth factor receptor kinase activation in vivo.

Li W, Li F, Huang Q, Frederick B, Bao S, Li CY. Li W, et al. Cancer Res. 2008 Jul 1;68(13):4990-7. doi: 10.1158/0008-5472.CAN-07-5984. Cancer Res. 2008. PMID: 18593895 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters